Related Experiment Video
Updated: Apr 5, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
NNMT: A Bad Actor in Fat Makes Good in Liver
Samuel A J Trammell1, Charles Brenner2
1Department of Biochemistry, Carver College of Medicine, University of Iowa, Iowa City, IA 52242; Program in Genetics, Carver College of Medicine, University of Iowa, Iowa City, IA 52242.
Nicotinamide N-methyltransferase (NNMT) enzyme expression in fat correlates with obesity. However, high liver NNMT expression improves lipid profiles by stabilizing SIRT1, despite potential weight gain implications.
Area of Science:
- Biochemistry
- Metabolism
- Obesity Research
Background:
- Nicotinamide N-methyltransferase (NNMT) is an enzyme involved in nicotinamide metabolism.
- High adipose NNMT expression is linked to increased body fat.
- Previous studies suggested NNMT knockdown prevents weight gain in mice on high-fat diets.
Purpose of the Study:
- To investigate the role of hepatic NNMT expression in metabolic parameters.
- To explore the mechanism by which NNMT influences lipid profiles.
- To examine the relationship between NNMT and SIRT1 in the liver.
Main Methods:
- Analysis of NNMT expression in adipose tissue.
- Studies involving murine models with varying NNMT expression in liver and fat.
- Assessment of lipid parameters and SIRT1 activity in response to NNMT modulation.
Main Results:
- High adipose NNMT expression correlates with adiposity.
- Murine NNMT knockdown in fat and liver prevented weight gain on a high-fat diet.
- High hepatic NNMT expression was found to improve lipid parameters through SIRT1 stabilization.
Conclusions:
- Hepatic NNMT plays a distinct role in regulating lipid metabolism, separate from its role in adiposity.
- SIRT1 stabilization by hepatic NNMT is a key mechanism for improving lipid profiles.
- Targeting hepatic NNMT may offer therapeutic potential for metabolic disorders.
Related Concept Videos
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Role of Reduced Coenzymes NADH and FADH₂
Lipid Catabolism
Phase II Reactions: Acetylation Reactions
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...

